19 March 2018 - Request for correspondence between the HTA and Professor Birchall
The HTA was asked to provide copies of correspondence sent by Professor Birchall to the HTA in 2007 and 2008.
9 March 2018 - Amount of organs and total weight of human tissue received by HTA-licensed establishments
The HTA was asked to provide information on the total number of organs received by HTA-licensed establishments, distinguishing between living and deceased donations; and also sharing the amount of human tissue received (in weight) by these establishments.
9 March 2018 - HTA's social media policy
The HTA was asked to provide information on our social media policy and also to give a break down of our expenditure for our organisational accounts per calendar year (Facebook, Twitter).
5 March 2018 - Quality indicators and checks for ovarian tissue preservation and transplantation
The HTA was asked to provide information on the quality indicators for ovarian tissue preservation and transplantation for the purpose of fertility preservation, for patients who are undergoing cancer treatment. HTA was also questioned on the ongoing quality checks of post-cryopreservation tissues.
20 February 2018 - HTA reportable incidents for 2017
The HTA was asked to provide information on reportable incidents that took place in the 2017 calendar year.
29 January 2018 - Number of church officials working as representatives of the HTA
The HTA was asked to provide details on the number of church officials currently working as representatives of the HTA.
HTA's intranet software
The HTA was asked to provide information on its intranet software.
24 January 2018 - Energy supply contracts for HTA
The HTA was asked to provide information regarding energy supply contracts.
11 January 2018 - Details of flight bookings
The HTA was asked to provide details of any flight bookings made since January 2015.
Extending licences to cover the removal of tissue from the deceased for research
The Human Tissue Act 2004 requires that the removal of tissue from the deceased for research within the scope of the Act must always be licensed, on specified premises, and that specific minimum requirements are met.
This means that if, for example, a person wishes to remove relevant material from a deceased organ donor for research ‘in connection with disorders, or the functioning, of the human body’, the removal must always take place on premises licensed by the HTA for that purpose.